Indications
Natamycin is clinically utilized for the management of fungal infections affecting the eye, specifically in cases of blepharitis, conjunctivitis, and keratitis. These conditions are typically caused by susceptible fungal organisms, including Fusarium solani, among others. Its application is targeted at treating these localized infections effectively.
Pharmacodynamics
Natamycin is categorized as an antifungal agent specifically designed for topical ophthalmic use. Extracted from Streptomyces natalensis, it is a tetraene polyene antibiotic demonstrating significant in vitro activity against various yeast and filamentous fungi. This includes activity against genera such as Candida, Aspergillus, Cephalosporium, Fusarium, and Penicillium. While the antifungal efficacy of natamycin is influenced by dosage, it primarily serves as a fungicidal agent. However, it does not exhibit activity against gram-positive or gram-negative bacteria. When applied topically, natamycin achieves therapeutic concentrations within the corneal stroma, though it does not penetrate into intraocular fluids.
Absorption
Natamycin is characterized by minimal systemic absorption when administered topically. This is consistent with other polyene antibiotics, which generally display poor absorption from the gastrointestinal tract. Consequently, significant systemic exposure and effects are not anticipated following topical application of the drug.
Mechanism of Action
Natamycin functions as an antifungal agent by specifically targeting the sterols present in fungal cell membranes. It binds to ergosterol, a key component of these membranes, and consequently interrupts critical processes such as the fusion of vacuoles and membrane fusion and fission. This action prevents the normal growth and development of fungal cells. Unlike many other polyene antibiotics that operate by changing membrane permeability, Natamycin's unique mechanism lies in its ability to inhibit ergosterol-dependent activities directly.
